Overview
Ocular motor apraxia, Cogan type (also known as Cogan-type oculomotor apraxia or congenital ocular motor apraxia) is a rare neurological condition characterized by the inability to initiate voluntary horizontal eye movements (saccades). First described by Dr. David Cogan in 1952, this condition primarily affects the ocular motor system, specifically the control of horizontal gaze. Affected individuals have difficulty directing their eyes toward a target of interest and instead develop a characteristic compensatory head thrust — a rapid, exaggerated turning of the head past the target — to shift gaze. Once the eyes fixate on the new target, the head slowly rotates back to a normal position. Vertical eye movements are typically preserved. The condition is usually noticed in infancy or early childhood when parents observe abnormal head movements. The underlying cause of Cogan-type ocular motor apraxia in its isolated (non-syndromic) form is not fully understood, though it is believed to involve developmental abnormalities in the brainstem or cerebral pathways that control saccadic eye movements. It is important to distinguish this isolated form from ocular motor apraxia that occurs as part of broader neurological syndromes such as ataxia-oculomotor apraxia types 1 and 2 (AOA1, AOA2) or ataxia-telangiectasia, which involve progressive cerebellar degeneration and other systemic features. In the isolated Cogan type, neurological development is generally normal, and many children show gradual improvement in their ability to generate voluntary saccades over time, with symptoms often becoming less prominent by adolescence. There is no specific curative treatment for Cogan-type ocular motor apraxia. Management is primarily supportive and includes regular ophthalmological and neurological follow-up. Occupational therapy and educational accommodations may be helpful, particularly for reading difficulties that can arise from impaired horizontal saccades. Neuroimaging may be recommended to rule out structural brain abnormalities. The prognosis for the isolated form is generally favorable, as the compensatory head movements tend to diminish with age and functional adaptation improves.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Ocular motor apraxia, Cogan type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Ocular motor apraxia, Cogan type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Ocular motor apraxia, Cogan type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Ocular motor apraxia, Cogan type.
Community
No community posts yet. Be the first to share your experience with Ocular motor apraxia, Cogan type.
Start the conversation →Latest news about Ocular motor apraxia, Cogan type
No recent news articles for Ocular motor apraxia, Cogan type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Ocular motor apraxia, Cogan type
What is Ocular motor apraxia, Cogan type?
Ocular motor apraxia, Cogan type (also known as Cogan-type oculomotor apraxia or congenital ocular motor apraxia) is a rare neurological condition characterized by the inability to initiate voluntary horizontal eye movements (saccades). First described by Dr. David Cogan in 1952, this condition primarily affects the ocular motor system, specifically the control of horizontal gaze. Affected individuals have difficulty directing their eyes toward a target of interest and instead develop a characteristic compensatory head thrust — a rapid, exaggerated turning of the head past the target — to shif
At what age does Ocular motor apraxia, Cogan type typically begin?
Typical onset of Ocular motor apraxia, Cogan type is infantile. Age of onset can vary across affected individuals.